Clinical Trial Update: Effect of Empagliflozin on Quality of Life in Chronic Heart Failure Patients With Diabetes Mellitus Type II [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating empagliflozin's effect on quality of life in patients with chronic heart failure and type 2 diabetes, and recruitment is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Fazaia Ruth Pfau Medical College | Conditions: Chronic Heart Failure | Phase 4 | Status: RECRUITING